Regeneron · 12 hours ago
Summer 2026 Intern- Masters or PhD in Training Development, Instructional Design, Education, or Related Majors
United States
Internship
Remote
Intern
$17.90/hr - $50.90/hr
Start in 2026 SummerRegeneron Pharmaceuticals is seeking a Summer 2026 Intern for their Commercial Training department. The role is aimed at graduate students pursuing a Masters or PhD in relevant fields, focusing on training, instructional design, and project management within a fully remote environment.
BiopharmaBiotechnologyPharmaceutical
Responsibilities
Achieving a general understanding of what happens in our global organization
Completing hands-on project work that has an impact on the business
Engaging with Regeneron leadership
Collaborating with other interns
Establishing connections with Regeneron’s diverse employee resource groups
Participating in professional development sessions while enjoying lots of free food and swag
Showcasing the knowledge you gained through end of program presentation sessions
Getting paid for your hard work!
Qualification
Required
Pursuing a Masters or PhD degree in Education, Instructional Design, I/O Psychology, or related
Knowledge of Microsoft Word, Excel, PowerPoint, SharePoint, Teams
Able to commit to 40 hours per week for a minimum of 10 weeks from the end of May/ early June through August
Preferred
A cumulative GPA of 3.0 is preferred
Demonstrated leadership in areas such as campus activities, clubs, sports, current or previous work, or within the community is also preferred
Benefits
Health and wellness programs (including medical, dental, vision, life, and disability insurance)
Fitness centers
401(k) company match
Family support benefits
Equity awards
Annual bonuses
Paid time off
Paid leaves (e.g., military and parental leave)
Company
Regeneron
Regeneron Pharmaceuticals specializes in the discovery, development, and commercialization of innovative medicines.
Founded in 1988
10001+ employees
Funding
Current Stage
Public CompanyTotal Funding
$15.93MKey Investors
U.S. Department of Health & Human Services
2024-07-11Post Ipo Equity· $2.03M
2023-10-18Post Ipo Equity· $5M
2016-08-22Post Ipo Equity· $8.9M
Leadership Team
Aris Baras
Senior Vice President, Regeneron Pharmaceuticals, General Manager, Regeneron Genetics Center
Bari Kowal
Senior Vice President, Head Development Operations & Portfolio Management
Recent News
2026-01-13
2026-01-09
Company data provided by crunchbase